At the conclusion of this activity, the participants will be able to:

Discuss the epidemiology and pathophysiology of PE, including how to assess the risk of patients presenting with symptoms consistent with PE.

Identify features that define low, intermediate and high‐risk PE.

Appreciate the impact of healthcare disparities on the diagnosis, management and outcome socially disadvantaged groups with VTE.

Determine the role and clinical evidence for the various treatment options for intermediate‐ and high‐risk PE patients including: anticoagulation, fibrinolysis (intravenous and catheter‐directed), thrombectomy (suction and surgical), and IVC filter placement.

Recognize the potential complications of acute PE and how to prevent and treat including support of the high risk PE patient and those requiring mechanical circulatory support.

Describe an algorithm to follow, evaluate and manage patients with post-PE syndrome.

Discuss CTEPH and the combination of pharmacologic, mechanical and surgical treatment options available for these patients.

Describe special populations with PE and their specific treatment challenges, including patients with active malignancy, coagulopathies, pregnancy, and those from socially disadvantaged groups.

Discuss the benefits of a multidisciplinary approach to PE management, and how to implement a PE Response Team (PERT) in their hospital.

Identify what constitutes high quality care for PE and how to establish a Center of Excellence in PE management.

Describe the benefits of a multidisciplinary coordinated response to the care of PE patients including acute management, inter-hospital transfer of patients, and long term follow up.


The Pulmonary Embolism Symposium will be a benefit to any physician in the following specialties – pulmonary/critical care, cardiology, radiology, hematology, vascular medicine, emergency medicine – who wish to expand their knowledge in the realm of PE care.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Behind the Scenes. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation

Amedco LLC designates this live activity for a maximum of 17.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy Statement

Behind the Scenes adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Disclosure of Unlabeled Use

Behind the Scenes requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.